EX-99.2 5 c65905ex99-2.txt SPSS'S RESTATED AUDITED FINANCIAL STMTS & NOTES EXHIBIT 99.2 SPSS INC. AND SUBSIDIARIES INDEX TO FINANCIAL STATEMENTS
PAGE ---- Consolidated Balance Sheets as of December 31, 1999 and 2000...................................................... 1 Consolidated Statements of Income for the years ended December 31, 1998, 1999 and 2000.......................... 2 Consolidated Statements of Comprehensive Income for the years ended December 31, 1998, 1999 and 2000.............. 3 Consolidated Statements of Stockholders' Equity for the years ended December 31, 1998, 1999 and 2000.............. 4 Consolidated Statements of Cash Flows for the years ended December 31, 1998, 1999 and 2000.......................... 5 Notes to Consolidated Financial Statements.................. 6 Financial Statement Schedule: Schedule II Valuation and qualifying accounts............... 24
Schedules not filed All schedules other than that indicated in the index have been omitted as the required information is inapplicable or the information is presented in the consolidated financial statements or related notes. SPSS INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
DECEMBER 31, DECEMBER 31, 1999 2000 ------------ ------------ (IN THOUSANDS, EXCEPT SHARE DATA) ASSETS CURRENT ASSETS: Cash and cash equivalents................................. $ 28,447 $ 27,887 Marketable securities..................................... 18,387 10,849 Accounts receivable, net of allowances of $3,240 in 1999 and $3,542 in 2000..................................... 51,749 72,611 Inventories............................................... 2,895 3,936 Deferred income taxes..................................... 6,349 10,334 Prepaid expenses and other current assets................. 4,564 7,336 -------- -------- Total current assets................................... 112,391 132,953 -------- -------- PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, at cost: Land and building......................................... 1,671 1,551 Furniture, fixtures, and office equipment................. 8,395 9,141 Computer equipment and software........................... 29,810 38,431 Leasehold improvements.................................... 6,795 8,916 -------- -------- 46,671 58,039 Less accumulated depreciation and amortization............ 28,472 32,931 -------- -------- Net property, equipment and leasehold improvements.......... 18,199 25,108 -------- -------- Capitalized software development costs, net of accumulated amortization.............................................. 13,078 16,142 Goodwill, net of accumulated amortization................... 5,395 8,106 Other assets................................................ 3,746 7,190 -------- -------- $152,809 $189,499 ======== ======== LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Notes payable............................................. $ 9,000 $ 16,000 Accounts payable.......................................... 6,993 9,901 Accrued royalties......................................... 1,030 986 Accrued rent.............................................. 1,050 1,438 Other accrued liabilities................................. 12,141 13,388 Income taxes and value added taxes payable................ 3,664 3,245 Customer advances......................................... 529 442 Deferred revenues......................................... 23,876 42,183 -------- -------- Total current liabilities.............................. 58,283 87,583 -------- -------- Deferred income taxes....................................... 3,886 749 Other non-current liabilities............................... 2,432 1,967 STOCKHOLDERS' EQUITY: Common stock, $.01 par value; 50,000,000 shares authorized; 13,160,036 and 13,632,445 shares issued and outstanding in 1999 and 2000, respectively............. 132 136 Additional paid-in capital................................ 80,081 86,960 Accumulated other comprehensive loss...................... (5) (3,108) Deferred compensation..................................... (426) (338) Retained earnings......................................... 8,426 15,550 -------- -------- Total stockholders' equity............................. 88,208 99,200 -------- -------- $152,809 $189,499 ======== ========
The accompanying notes are an integral part of these consolidated financial statements. 1 SPSS INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME
YEAR ENDED DECEMBER 31, --------------------------------------- 1998 1999 2000 ----------- ----------- ----------- (IN THOUSANDS, EXCEPT SHARE DATA) Net revenues: Analytical solutions................................ $ 8,836 $ 17,540 $ 31,246 Market research..................................... 25,551 32,674 29,688 Statistics.......................................... 89,085 91,716 78,846 ShowCase............................................ 35,519 39,523 46,334 ----------- ----------- ----------- Net revenues.......................................... 158,991 181,453 186,114 ----------- ----------- ----------- Operating expenses: Cost of revenues.................................... 13,857 16,500 16,268 Sales and marketing................................. 85,099 98,824 115,074 Product development................................. 25,233 30,465 32,896 General and administrative.......................... 12,639 14,239 14,045 Special general and administrative charges.......... 445 -- -- Merger-related...................................... 1,948 1,611 -- Acquired in-process technology...................... 3,552 128 -- ----------- ----------- ----------- Operating expenses.................................... 142,773 161,767 178,283 ----------- ----------- ----------- Operating income...................................... 16,218 19,686 7,831 ----------- ----------- ----------- Other income (expense): Net interest and investment income............... 446 739 1,096 Other............................................ (98) 304 1,222 ----------- ----------- ----------- Other income.......................................... 348 1,043 2,318 ----------- ----------- ----------- Income before income taxes............................ 16,566 20,729 10,149 Income tax expense.................................... 7,926 7,492 4,234 ----------- ----------- ----------- Net income............................................ $ 8,640 $ 13,237 $ 5,915 =========== =========== =========== Basic net income per share............................ $ 0.79 $ 1.05 $ 0.44 =========== =========== =========== Shares used in computing basic net income per share... 10,976,524 12,562,316 13,372,917 =========== =========== =========== Diluted net income per share.......................... $ 0.73 $ 0.98 $ 0.41 =========== =========== =========== Shares used in computing diluted net income per share............................................... 11,796,683 13,503,848 14,326,552 =========== =========== ===========
The accompanying notes are an integral part of these consolidated financial statements. 2 SPSS INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
YEAR ENDED DECEMBER 31, -------------------------- 1998 1999 2000 ------ ------- ------- (IN THOUSANDS) Net income.................................................. $8,640 $13,237 $ 5,915 Other comprehensive income (loss): Foreign currency translation adjustment................... 128 834 (3,107) Unrealized holding gain (loss) on marketable securities... (304) 172 4 ------ ------- ------- Comprehensive income........................................ $8,464 $14,243 $ 2,812 ====== ======= =======
The accompanying notes are an integral part of these consolidated financial 3 SPSS INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
YEAR ENDED DECEMBER 31, ---------------------------------- 1998 1999 2000 ---------- --------- --------- (IN THOUSANDS, EXCEPT SHARE DATA) Common stock, $.01 par value: Balance at beginning of period............................ $ 116 $ 120 $ 132 Sale of 18,663, 30,131 and 30,038 shares of common stock to the Employee Stock Purchase Plans in 1998, 1999 and 2000, respectively..................................... -- -- -- Stock issued pursuant to public offering.................. -- 10 -- Exercise of stock options and other....................... 4 2 4 -------- ------- ------- Balance at end of period.................................. $ 120 $ 132 $ 136 -------- ------- ------- Additional paid-in capital: Balance at beginning of period............................ $ 50,395 $54,091 $80,081 Sale of 18,663, 30,131 and 30,038 shares of common stock to the Employee Stock Purchase Plans in 1998, 1999 and 2000, respectively..................................... 522 762 725 Sale of 54,606 shares of common stock in 1998............. 488 -- -- Stock issued pursuant to public offering.................. -- 24,340 -- Exercise of stock options and other....................... 1,323 325 4,091 Stock-based compensation.................................. 355 152 304 Stock options issued to consultant........................ -- 60 -- Income tax benefit related to stock options............... 1,008 351 1,759 -------- ------- ------- Balance at end of period.................................. $ 54,091 $80,081 $86,960 -------- ------- ------- Accumulated other comprehensive income (loss): Balance at beginning of period............................ $ (835) $(1,011) $ (5) Foreign currency translation adjustment................... 128 834 (3,107) Unrealized holding gain (loss) on marketable securities... (304) 172 4 -------- ------- ------- Balance at end of period.................................. $ (1,011) $ (5) $(3,108) -------- ------- ------- Deferred compensation: Balance at beginning of period............................ $ -- $ (322) $ (426) Deferred compensation..................................... (355) (152) -- Stock options issued to consultant........................ -- (60) -- Amortization of deferred compensation..................... 33 108 88 -------- ------- ------- Balance at end of period.................................. $ (322) $ (426) $ (338) -------- ------- ------- Retained earnings (accumulated deficit): Balance at beginning of period............................ $(13,451) $(4,811) $ 8,426 Net income................................................ 8,640 13,237 5,915 Adjustment to conform fiscal years of pooled business..... -- -- 1,209 -------- ------- ------- Balance at end of period.................................. $ (4,811) $ 8,426 $15,550 -------- ------- ------- Total stockholders' equity.................................. $ 48,067 $88,208 $99,200 ======== ======= =======
The accompanying notes are an integral part of these consolidated financial statements. 4 SPSS INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
YEAR ENDED DECEMBER 31, -------------------------------- 1998 1999 2000 -------- --------- --------- (IN THOUSANDS) Cash flows from operating activities: Net income................................................ $ 8,640 $ 13,237 $ 5,915 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization........................... 7,732 9,660 11,957 Provision for returns and doubtful accounts, net of returns and write-offs................................. 305 (90) -- Compensation expense related to options................. 33 108 392 Deferred income taxes................................... (2,234) 431 (7,122) Gain on sale of product line............................ -- -- (1,397) Income tax benefit from stock options exercised......... 1,008 351 1,759 Write-off of acquired in-process technology............. 3,552 128 -- Changes in assets and liabilities, net of effects of acquisitions: Accounts receivable................................... (6,985) (9,774) (20,862) Inventories........................................... (164) (24) (1,541) Prepaid expenses and other current assets............. 224 (672) (1,638) Accounts payable...................................... 960 (642) 2,907 Income taxes payable.................................. 295 (295) 293 Accrued royalties..................................... 89 (83) 44 Accrued expenses...................................... (258) (1,996) (1,160) Accrued income taxes.................................. 4,423 (2,213) 419 Deferred revenue...................................... 3,896 (628) 18,307 Other................................................. 1,462 (1,445) (1,299) -------- --------- --------- Net cash provided by operating activities................... 22,978 6,053 6,974 -------- --------- --------- Cash flows from investing activities: Capital expenditures, net................................. (11,056) (5,162) (12,684) Purchase of marketable securities......................... -- (133,496) (152,138) Proceeds from maturities and sale of marketable securities.............................................. 32 115,571 159,680 Divesture of product line/affiliate, net.................. 218 -- 1,700 Purchase of cost-basis investment......................... -- -- (1,450) Purchase of software license.............................. -- -- (1,000) Capitalized software development costs.................... (4,070) (5,597) (7,602) Acquisition earn-out payments............................. -- -- (3,882) Net payments related to acquisitions...................... (8,404) (83) -- -------- --------- --------- Net cash used in investing activities....................... (23,280) (28,767) (17,376) -------- --------- --------- Cash flows from financing activities: Net (repayments) borrowings under line-of-credit agreements.............................................. 7,638 (48) 7,000 Proceeds from issuance of common stock.................... 2,337 1,089 4,820 Proceeds from initial public offering, net of expenses.... -- 24,350 -- Payments under capital lease obligations.................. (136) (134) (80) -------- --------- --------- Net cash provided by financing activities................... 9,839 25,257 11,740 -------- --------- --------- Effect of exchange rate on cash............................. 189 707 (3,107) Adjustment to conform fiscal years of pooled businesses..... -- -- 1,209 -------- --------- --------- Net change in cash and cash equivalents..................... 9,726 3,250 (560) Cash and cash equivalents at beginning of period............ 15,471 25,197 28,447 -------- --------- --------- Cash and cash equivalents at end of period.................. $ 25,197 $ 28,447 $ 27,887 ======== ========= ========= Supplemental disclosures of cash flow information: Interest paid............................................. $ 363 $ 959 $ 1,063 Income taxes paid......................................... 6,464 12,093 9,363 Cash received for income tax refunds...................... 395 26 234 ======== ========= =========
The accompanying notes are an integral part of these consolidated financial statements. 5 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (1) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (a) DESCRIPTION OF BUSINESS SPSS Inc. ("SPSS" or the "Company") is a multinational company that provides software and professional services for discovering what customers want and predicting what they will do. The Company's products and services, individually and in combination, are primarily used by commercial organizations to integrate and analyze market, customer, and operational data in the process of formulating strategies and programs to interact with their customers more effectively. This process is commonly called "data mining" or "data analysis using advanced analytical techniques." In connection with the merger with ShowCase Corporation ("ShowCase") in 2001, the Company introduced a Windows-based query tool for the IBM AS/400, ShowCase Vista. ShowCase has subsequently introduced additional products and services to support an end-to-end business intelligence solution for IBM AS/400 customers. ShowCase's product suite is sold under the name ShowCase Strategy. Analytical solutions include products and services, sold separately or in combination, for customer relationship management, business intelligence, and business performance measurement applications. Market research includes products and services, sold separately or in combination, for survey design, implementation, and analysis in the market research industry. Statistics include products and services, sold separately or in combination, for general purpose statistical analysis. (b) PRINCIPLES OF CONSOLIDATION The consolidated financial statements include the accounts of SPSS Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. (c) USE OF ESTIMATES Management of SPSS has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. (d) SOFTWARE REVENUE RECOGNITION The Company applies AICPA Statement of Position ("SOP") 97-2, Software Revenue Recognition and related interpretations, which specifies the criteria that must be met prior to SPSS recognizing revenues from software sales. SPSS primarily recognizes revenue from product licenses, net of an allowance for estimated returns and cancellations, at the time the software is delivered. Revenue from certain product license agreements is recognized upon contract execution, product delivery, and customer acceptance. Revenue from postcontract customer support ("PCS" or "maintenance") agreements, including PCS bundled with product licenses, is recognized ratably over the term of the related PCS agreements. Some product licenses include commitments for insignificant obligations, such as technical and other support, for which an accrual is provided. Revenue from training, consulting, publications, and other items is recognized as the related products or services are delivered or rendered. Revenues from fixed-price contracts are recognized using the percentage-of-completion method of contract accounting as services are performed to develop, customize and install the Company's software products. The percentage completed is measured by the percentage of labor hours incurred to date in relation 6 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) to estimated total labor hours for each contract. Management considers labor hours to be the best available measure of progress on these contracts. During 2000, the AICPA staff released several Technical Practice Aids ("TPA") for the software industry, consisting of questions and answers related to the financial accounting and reporting issues of Statement of Position 97-2, Software Revenue Recognition. As a result of the issuance of these TPA's, SPSS performed a comprehensive review of their revenue recognition policies to ensure compliance with recent authoritative literature. On a prospective basis beginning in the fourth quarter of 2000, SPSS applied the standards set forth in TPA 5100.53 -- Fair value of PCS in a short-term time-based license and software revenue recognition and TPA 5100.68 -- Fair value of PCS in perpetual and multi-year time-based licenses and software revenue recognition. As a result of the application of the TPA's, SPSS recognized the revenue from short-term time-based licenses and perpetual licenses with multi-year maintenance terms ratable over the term of the contract. The Company recorded a one-time adjustment of approximately $16,975,000 to defer revenue for contracts entered into during the fourth quarter of 2000. (e) SOFTWARE DEVELOPMENT COSTS Software development costs incurred by SPSS in connection with the Company's long-term development projects are capitalized in accordance with Statement of Financial Accounting Standards ("SFAS") No. 86, Accounting for the Costs of Computer Software to Be Sold, Leased, or Otherwise Marketed. SPSS has not capitalized software development costs relating to development projects where the net realizable value is of short duration, as the effect would be immaterial. SPSS reviews capitalized software development costs each period and, if necessary, reduces the carrying value of each product to its net realizable value. (f) EARNINGS PER SHARE Basic earnings per share ("EPS") is based on the weighted average number of shares outstanding and excludes the dilutive effect of unexercised common stock equivalents. Diluted EPS is based on the weighted average number of shares outstanding and includes the dilutive effect of unexercised common stock equivalents.
YEAR ENDED DECEMBER 31, --------------------------------------- 1998 1999 2000 ----------- ----------- ----------- BASIC EPS Net income.................................... $ 8,640,000 $13,237,000 $ 5,915,000 Weighted-average number of common shares outstanding................................. 10,976,524 12,562,316 13,372,917 Basic EPS..................................... $ 0.79 $ 1.05 $ 0.44 =========== =========== =========== DILUTED EPS Net income.................................... $ 8,640,000 $13,237,000 $ 5,915,000 Weighted-average number of common shares outstanding................................. 10,976,524 12,562,316 13,372,917 Effect of dilutive securities-stock options... 820,159 941,532 953,635 ----------- ----------- ----------- Weighted-average number of common shares and common share equivalents that would be issued upon exercise........................ 11,796,683 13,503,848 14,326,552 ----------- ----------- ----------- Diluted EPS................................... $ 0.73 $ 0.98 $ 0.41 =========== =========== =========== Anti-dilutive shares not included in diluted EPS calculation............................. 208,694 157,753 85,357 =========== =========== ===========
7 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (g) DEPRECIATION AND AMORTIZATION Depreciation of buildings is provided over thirty years on a straight-line method. Furniture and equipment is depreciated using the straight-line method over the estimated useful lives of the assets, which range from three to ten years. Leasehold improvements are amortized on the straight-line method over the remaining terms of the respective leases. Capitalized software costs are amortized on a straight-line method over three to five years based upon the expected life of each product. This method results in greater amortization than the method based upon the ratio of current year gross product revenue to current and anticipated future gross product revenue. As of January 1, 1998, SPSS adopted SOP 98-1, Accounting for the Costs of Computer Software Developed or Obtained for Internal Use. This standard requires that certain costs related to the development or purchase of internal-use software be capitalized and amortized over the estimated useful life of the software. SOP 98-1 also requires that costs related to the preliminary project stage and post-implementation/operations stage of an internal-use computer software development project be expensed as incurred. During 1998, 1999 and 2000 SPSS capitalized $873,000, $739,000 and $1,229,000 and amortized $6,000, $23,000 and $40,000 of internal-use computer software. (h) INCOME TAXES SPSS applies the asset and liability method of accounting for income taxes in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. (i) STOCK OPTION PLANS The Company accounts for its stock options under the provisions of SFAS No. 123, Accounting for Stock-Based Compensation. SFAS No. 123 permits entities to recognize as expense over the vesting period the fair value of all stock-based awards on the date of grant. Alternatively, SFAS No. 123 also allows entities to apply the provisions of Accounting Principles Board Opinion ("APB") No. 25, Accounting for Stock Issued to Employees and provide pro forma net income (loss) disclosures for employee stock option grants made as if the fair value-based method defined in SFAS No. 123 had been applied. Under APB No. 25, compensation expense would be recorded on the date of the grant only if the current market price of the underlying stock exceeded the exercise price. The Company has elected to apply the provisions of APB No. 25 and provide the pro forma disclosures required by SFAS No. 123. (j) INVENTORIES Inventories, consisting of finished goods, are stated at the lower of cost or market. Cost is determined using the first-in, first-out method. (k) GOODWILL The excess of the cost over the fair value of net assets acquired is recorded as goodwill and amortized on a straight-line basis over 5 to 15 years. Accumulated amortization was $1,575,000 and $2,718,000 as of December 31, 1999 and 2000, respectively. When goodwill exceeds associated expected operating cash flows, it is considered to be impaired and is written down to fair value, which is determined based on discounted cash flows. 8 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (l) FOREIGN CURRENCY TRANSLATION The translation of the applicable foreign currencies into U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using the average exchange rates during the period. The gains or losses resulting from such translation are included in stockholders' equity. Gains or losses resulting from foreign currency transactions are included in "other income and expense" in the statement of income. (m) FAIR VALUE OF FINANCIAL INSTRUMENTS The fair values of financial instruments were not materially different from their carrying values. (n) CASH AND CASH EQUIVALENTS Cash and cash equivalents are comprised of highly liquid investments with original maturity dates of three months or less. (o) MARKETABLE SECURITIES All marketable securities are classified as available-for-sale and available to support current operations or to take advantage of other investment opportunities. These securities are stated at estimated fair values based upon market quotes with unrealized holding gains or losses reported as a separate component of accumulated other comprehensive income within stockholders' equity. Realized gains and losses are included in other income (expense). The cost of securities sold is based on the specific identification method. The cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. This amortization and accretion is included in net interest and investment income (expense). (p) LONG-LIVED ASSETS Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount should be evaluated. Factors leading to impairment include a combination of historical losses, anticipated future losses and inadequate cash flow. The assessment of recoverability is based on management's estimate. Impairment is assessed by comparing the carrying value to the estimated and undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. Impairment is measured based on discounted cash flows. SPSS has determined that as of December 31, 2000, there has been no impairment in the carrying values of long-lived assets. (q) ADVERTISING EXPENSES Advertising expenses are charged to operations during the year in which they are incurred. The total amount of advertising expenses charged to operations was $4,291,000, $3,557,000 and $2,852,000 for the years ended December 31, 1998, 1999 and 2000, respectively. (r) RECLASSIFICATIONS Where appropriate, some items relating to the prior years have been reclassified to conform to the presentation in the current year. 9 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (2) DOMESTIC AND FOREIGN OPERATIONS The net assets, net revenues and net income of international subsidiaries as of and for the years ended December 31, 1998, 1999 and 2000 included in the consolidated financial statements are summarized as follows:
DECEMBER 31, --------------------------------------- 1998 1999 2000 ----------- ----------- ----------- Working capital............................... $ 8,431,000 $18,703,000 $26,616,000 =========== =========== =========== Excess of noncurrent assets over noncurrent liabilities................................. $ 3,522,000 $ 4,391,000 $ 5,939,000 =========== =========== =========== Net revenues.................................. $69,227,000 $83,382,000 $80,143,000 =========== =========== =========== Net income.................................... $ 7,082,000 $ 4,639,000 $ 6,874,000 =========== =========== ===========
Net revenues(1) per geographic region are summarized as follows:
YEAR ENDED DECEMBER 31, ------------------------------------------ 1998 1999 2000 ------------ ------------ ------------ United States.............................. $ 89,764,000 $ 98,071,000 $105,971,000 United Kingdom............................. 26,194,000 27,096,000 25,113,000 The Netherlands............................ 11,978,000 13,505,000 9,989,000 Japan...................................... 9,750,000 11,900,000 13,346,000 Germany.................................... 9,428,000 11,573,000 9,727,000 France..................................... 3,166,000 3,528,000 3,927,000 Other...................................... 8,711,000 15,780,000 18,041,000 ------------ ------------ ------------ $158,991,000 $181,453,000 $186,114,000 ============ ============ ============
--------------- (1) Revenues are attributed to countries based on point-of-sale. Long-lived assets per geographic region are summarized as follows:
DECEMBER 31, --------------------------------------- 1998 1999 2000 ----------- ----------- ----------- United States................................. $33,191,000 $35,661,000 $50,696,000 United Kingdom................................ 2,122,000 1,968,000 2,782,000 The Netherlands............................... 318,000 224,000 240,000 Japan......................................... 1,049,000 1,066,000 936,000 Germany....................................... 269,000 211,000 319,000 Other......................................... 912,000 1,288,000 1,573,000 ----------- ----------- ----------- $37,861,000 $40,418,000 $56,546,000 =========== =========== ===========
10 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (3) SOFTWARE DEVELOPMENT COSTS AND PURCHASED SOFTWARE Activity in capitalized software is summarized as follows:
DECEMBER 31, --------------------------------------- 1998 1999 2000 ----------- ----------- ----------- Balance, net -- beginning of year............. $ 6,703,000 $10,658,000 $13,078,000 Additions..................................... 5,500,000 3,961,000 7,018,000 Product translations.......................... 792,000 1,641,000 501,000 Write-down to net realizable value............ (445,000) -- -- Sale of assets................................ -- -- (294,000) Amortization expense charged to cost of revenues.................................... (1,892,000) (3,182,000) (4,161,000) ----------- ----------- ----------- Balance, net -- end of year................... $10,658,000 $13,078,000 $16,142,000 =========== =========== ===========
The components of net capitalized software are summarized as follows:
DECEMBER 31, ------------------------- 1999 2000 ----------- ----------- Product translations....................................... $ 2,798,000 $ 2,489,000 Acquired software technology............................... 4,720,000 5,477,000 Capitalized software development costs..................... 5,560,000 8,176,000 ----------- ----------- Balance, net -- end of year................................ $13,078,000 $16,142,000 =========== ===========
Total software development costs, including amounts expensed as incurred, amounted to approximately $29,303,000, $36,062,000 and $40,498,000, for the years ended December 31, 1998, 1999 and 2000, respectively. Included in acquired software technology at December 31, 1999 and 2000 is $1,782,000 and $1,337,000 of technology resulting from the purchase of Surveycraft Party Ltd., Integral Solutions Ltd. and the VerbaStat product. (See Note 4) (4) ACQUISITIONS AND DIVESTITURES ACQUISITIONS In November 1998, SPSS acquired all of the outstanding shares of capital stock of Surveycraft Pty. Ltd. ("Surveycraft") for an aggregate purchase price of approximately $1,700,000. The Surveycraft acquisition was accounted for as a purchase and, accordingly, the acquired assets and liabilities have been recorded at their estimated fair values. In the fourth quarter of 1998, SPSS recorded charges of approximately $863,000 representing a one-time write-off of acquired in-process technology and other merger-related costs. Surveycraft is a computer software company specializing in market research software. In 1999, SPSS consolidated the Surveycraft business into its Australia and Cincinnati offices. Also in 1999, some assumed liabilities were revalued, and goodwill was decreased by $371,000. On December 31, 1998, SPSS acquired all of the outstanding shares of capital stock of Integral Solutions Limited ("Integral Solutions"), a corporation incorporated under the laws of England, from the shareholders of Integral Solutions (the "Shareholders"). The stock purchase occurred pursuant to the Stock Purchase Agreement between SPSS and the Shareholders in the United Kingdom (the "Agreement") dated as of December 31, 1998. SPSS acquired Integral Solutions from the Shareholders for approximately $7,000,000 plus contingent payments (as defined in the Agreement) of up to approximately $7,000,000 based on future results of the acquired business (the "Purchase Price"). Additional payments of approximately $3,900,000 11 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) and $2,900,000 were made in January 2000 and February 2001, respectively. Additional payments were recorded as an adjustment to purchase price in the periods in which such payments were determinable. The Integral Solutions acquisition was accounted for as a purchase and, accordingly, the acquired assets and liabilities have been recorded at their estimated fair values. In the fourth quarter of 1998, SPSS recorded charges of approximately $5,082,000 representing a one-time write-off of acquired in-process technology and other merger-related costs. Integral Solutions is a leading full-service data mining company, supplying consultancy and training. In 1999, Integral Solution's office lease expired and personnel were moved to the existing SPSS UK Ltd. Offices in Woking, England. Also in 1999, some assumed liabilities were revalued, and goodwill was increased by $227,000. The following summary presents information concerning the purchase price allocations for the acquisitions accounted for under the purchase method for the year ended December 31, 1998.
ACQUIRED PURCHASED IN-PROCESS PURCHASE COMPANY NAME SOFTWARE TECHNOLOGY GOODWILL OTHER PRICE(1) ------------ ---------- ---------- ---------- ---------- ----------- Surveycraft....................... $ 202,000 $ 312,000 $1,974,000 $ 533,000 $ 3,021,000 Integral Solutions................ 2,020,000 3,240,000 2,239,000 1,741,000 9,240,000 ---------- ---------- ---------- ---------- ----------- $2,222,000 $3,552,000 $4,213,000 $2,274,000 $12,261,000 ========== ========== ========== ========== ===========
--------------- (1) Purchase price includes costs associated with the acquisition and acquired deferred tax liabilities. SPSS incurred significant costs and expenses in connection with these acquisitions, including professional fees, employees' severance and various other expenses. Such expenses were recorded as part of the purchase price in connection with the Surveycraft and Integral Solutions acquisitions accounted for as purchases. On November 29, 1999, SPSS acquired all of the outstanding shares of capital stock of Vento Software, Inc. ("Vento"), a corporation incorporated under the laws of Florida, from the shareholders of Vento in exchange for 546,060 shares of common stock in a stock acquisition accounted for as a pooling of interests and, accordingly, the consolidated financial statements have been restated as if SPSS and Vento had been combined for all periods presented. In the fourth quarter of 1999, SPSS recorded charges of approximately $1,611,000 representing merger-related costs for expenses relating to management and sales force restructuring, employee sign-on bonuses, professional fees and various other expenses. Vento is an analytical solutions company whose assets include the VentoMap product line, a series of industry-specific software products for business performance measurement, and a proprietary methodology for the delivery of related professional services. On December 24, 1999, SPSS acquired certain assets related to the VerbaStat software program from DataStat, S.A., a corporation organized under the laws of Belgium, for approximately $1,000,000. VerbaStat is a software tool for computer aided coding of open-ended survey questions. The following summary presents information concerning the purchase price allocation for the VerbaStat acquisition accounted for under the purchase method for the year ended December 31, 1999.
ACQUIRED PURCHASED IN-PROCESS PURCHASE COMPANY NAME SOFTWARE TECHNOLOGY GOODWILL OTHER PRICE ------------ --------- ---------- -------- -------- ---------- VerbaStat...................... $5,000 $128,000 $883,000 $138,000 $1,154,000
On February 26, 2001, the Company acquired all of the outstanding capital stock of ShowCase Corporation (ShowCase), in exchange for approximately 3,725,000 shares of common stock, which had a market value of approximately $63,958,000 at the time of the acquisition. The transaction was accounted for as a pooling of interests, and accordingly, the consolidated financial statements have been restated as if the combining 12 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) companies had been combined for all periods presented. Merger costs relating to the acquisition amounted to approximately $10.5 million. These costs included investment banking fees, legal and other professional fees, employee severance payments and various other expenses. The following information reconciles total revenues and net income of SPSS as previously reported in the Company's Annual Report on Form 10-K for the years ended December 31, 1998, 1999 and 2000 to those included in the accompanying consolidated financial statements.
1998 1999 2000 ------------ ------------ ------------ Net revenues: SPSS(1).................................. $123,472,000 $141,930,000 $139,780,000 ShowCase(2).............................. 35,519,000 39,523,000 46,334,000 ------------ ------------ ------------ Total............................... $158,991,000 $181,453,000 $186,114,000 ============ ============ ============ Net income (loss): SPSS(1).................................. $ 8,578,000 $ 15,502,000 $ 7,536,000 ShowCase(2).............................. 62,000 (2,265,000) (1,621,000) ------------ ------------ ------------ Total............................... $ 8,640,000 $ 13,237,000 $ 5,915,000 ============ ============ ============ Diluted net income per share............... $ 0.73 $ 0.98 $ 0.41 ============ ============ ============
--------------- (1) Represents the historical results of SPSS without considering the effect of the pooling of interests consummated with ShowCase during 2001. (2) Represents the historical results of ShowCase for the twelve months ended March 31, 1999, March 31, 2000 and December 31, 2000. The consolidated statement of income for the year ended December 31, 2000, reflects the impact of ShowCase operating results for the three months ended March 31, 2000, which are also included in the year ended December 31, 1999 consolidated statement of income due to differences in reporting periods reflective to SPSS. The revenues and net loss of ShowCase included more than once were $10,865,000 and ($1,209,000), respectively. DIVESTITURES On May 11, 2000, SPSS sold substantially all of the assets of its QI Analyst business to Wonderware Corporation for approximately $2,000,000, recording a gain in other income of $1,397,000. (5) COMMITMENTS AND CONTINGENCIES OPERATING LEASES SPSS leases its office facilities, storage space, and some data processing equipment under lease agreements expiring through the year 2012. Minimum lease payments indicated below do not include costs such as property taxes, maintenance, and insurance. 13 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) The following is a schedule of future noncancellable minimum lease payments required under operating leases as of December 31, 2000:
YEAR ENDING DECEMBER 31, AMOUNT ------------------------ ----------- 2001........................................................ $ 6,128,000 2002........................................................ 5,037,000 2003........................................................ 4,590,000 2004........................................................ 3,992,000 2005........................................................ 3,271,000 Thereafter.................................................. 15,262,000 ----------- $38,280,000 ===========
Rent expense related to operating leases was approximately $7,068,000, $7,422,000 and $8,500,000 during the years ended December 31, 1998, 1999 and 2000, respectively. LITIGATION SPSS is subject to certain legal proceedings and claims that have arisen in the ordinary course of business and have not been adjudicated. Marija J. Norusis ("Plaintiff") and SPSS entered into a series of publishing agreements pursuant to which Plaintiff agreed to author portions of certain software manuals and statistical guides. Plaintiff alleges that SPSS has published and sold certain manuals which contain Plaintiff's work and/or which Plaintiff had the right to prepare under the terms of the parties' agreements, without paying the Plaintiff royalties on such sales. Plaintiff filed a complaint, as amended, in which Plaintiff asserts claims for a declaratory judgment, an accounting, breach of contract, quantum meruit, and violation of the Illinois Deceptive Trade Practices Act. Plaintiff currently seeks unspecified damages in an amount in excess of $100,000 together with prejudgment interest and attorney's fees. On motion by SPSS, the court dismissed Plaintiff's declaratory claim, but all of the other claims are pending. In July 2000, the Court ordered the parties to retain an independent third party to analyze SPSS' records and to prepare a report of SPSS' sales of the software manuals and statistical guides for which Plaintiff claims a right to royalties. That report was completed in December 2000, and the parties are currently engaged in settlement discussions based on the report. SPSS intends to pursue settlement negotiations with Plaintiff, and, if those negotiations are unsuccessful, to vigorously contest Plaintiff's claims. See Note 13. (6) OTHER NON-CURRENT LIABILITIES SPSS has a mortgage on its freehold property, which houses the SPSS Limited Quantime offices in London, England. The mortgage is held by Norwich Union Investment Management of Norwich, England and is a fixed 12.04%, 30-year mortgage expiring in January 2010. The annual principal and interest payments total British Pounds Sterling (GBP) of 109,692 (approximately $166,000). The current portion of this debt is GBP 33,106 (approximately $50,000) and is included in "Other Accrued Liabilities" as of December 31, 2000. The non-current balance as of December 31, 2000 is GBP 553,510 (approximately $828,000). In December 1999, SPSS entered into an asset purchase agreement with DataStat, S.A. for the purchase of the VerbaStat product. Under the terms of the agreement, SPSS will pay DataStat twelve quarterly installment payments of $83,333. The current portion of this debt is approximately $250,000, and is included in "Other accrued liabilities" as of December 31, 2000. The non-current balance as of December 31, 2000 is $417,000. 14 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (7) FINANCING ARRANGEMENTS The Company has a loan agreement with American National Bank and Trust Company of Chicago. Under the agreement, SPSS has an available $20,000,000 unsecured line of credit. At December 31, 2000, SPSS had $16,000,000 in borrowings under this credit agreement. Borrowings against the line of credit bear interest at either the prime interest rate or the Eurodollar Rate (varying between 8.21% and 8.37% at December 31, 2000), depending on the circumstances. As of January 26, 2001, the Company amended its June 1, 2000 line of credit to make an additional $5,000,000 available until April 30, 2001. The Company has a $3,000,000 revolving line of credit agreement with a bank through August 30, 2001, bearing interest at the bank's base rate plus .25%. Borrowings are limited to 75% of eligible accounts receivable and are payable on demand. The revolving line of credit note is secured by substantially all of the Company's assets and contains certain restrictive financial covenants, including liquidity, profitability and the maintenance of prescribed tangible net worth and debt to tangible net worth ratios. No borrowings were outstanding under the line of credit at December 31, 2000. (8) OTHER INCOME (EXPENSE) Other income (expense) consists of the following:
YEAR ENDED DECEMBER 31, ------------------------------------- 1998 1999 2000 ---------- ---------- ----------- Interest and investment income.................. $1,364,000 $1,482,000 $ 2,196,000 Interest expense................................ (918,000) (743,000) (1,100,000) Exchange gain (loss) on foreign currency transactions.................................. (238,000) 119,000 (224,000) Gain on sale of product line.................... -- -- 1,397,000 Other........................................... 140,000 185,000 49,000 ---------- ---------- ----------- Total other income (expense).................... $ 348,000 $1,043,000 $ 2,318,000 ========== ========== ===========
(9) INCOME TAXES Income (loss) before income tax consists of the following:
YEAR ENDED DECEMBER 31, --------------------------------------- 1998 1999 2000 ----------- ----------- ----------- Domestic...................................... $ 4,970,000 $ 4,029,000 $(1,452,000) Foreign....................................... 11,596,000 16,700,000 11,601,000 ----------- ----------- ----------- $16,566,000 $20,729,000 $10,149,000 =========== =========== ===========
15 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) Income tax expense (benefit) consists of the following:
CURRENT DEFERRED TOTAL ----------- ----------- ----------- Year ended December 31, 1998 U.S. Federal................................ $ 4,249,000 $(2,029,000) $ 2,220,000 State....................................... 919,000 (161,000) 758,000 Foreign..................................... 4,192,000 756,000 4,948,000 ----------- ----------- ----------- $ 9,360,000 $(1,434,000) $ 7,926,000 =========== =========== =========== Year ended December 31, 1999 U.S. Federal................................ $ 2,479,000 $(1,101,000) $ 1,378,000 State....................................... 495,000 19,000 514,000 Foreign..................................... 5,423,000 177,000 5,600,000 ----------- ----------- ----------- $ 8,397,000 $ (905,000) $ 7,492,000 =========== =========== =========== Year ended December 31, 2000 U.S. Federal................................ $ 2,856,000 $(7,142,000) $(4,286,000) State....................................... 926,000 (845,000) 81,000 Foreign..................................... 8,274,000 165,000 8,439,000 ----------- ----------- ----------- $12,056,000 $(7,822,000) $ 4,234,000 =========== =========== ===========
For the years ended December 31, 1998, 1999 and 2000, the reconciliation of statutory to effective income taxes is as follows:
YEAR ENDED DECEMBER 31, ------------------------------------ 1998 1999 2000 ---------- ---------- ---------- Income taxes using the Federal statutory rate of 34%............................................ $5,632,000 $7,048,000 $3,791,000 State income taxes, net of Federal tax benefit... 500,000 299,000 (226,000) Foreign taxes at net rates different from U.S. Federal rates.................................. 389,000 (78,000) 2,463,000 Foreign tax credit............................... (642,000) -- (703,000) Nondeductible write-off of in-process research and development................................ 1,208,000 128,000 -- Acquisition costs................................ 785,000 404,000 -- Change in valuation allowance.................... -- (867,000) (855,000) Other, net....................................... 54,000 558,000 (236,000) ---------- ---------- ---------- $7,926,000 $7,492,000 $4,234,000 ========== ========== ==========
16 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at December 31, 1999 and 2000, are presented below:
1999 2000 ----------- ----------- Deferred tax assets: Accounts receivable principally due to allowance for doubtful accounts..................................... $ 639,000 $ 559,000 Inventories, principally due to additional costs inventoried for tax purposes pursuant to the Tax Reform Act of 1986.................................... 51,000 55,000 Compensated absences, principally due to accrual for financial reporting purposes.......................... 365,000 506,000 Foreign tax credit carryforwards......................... 220,000 356,000 Research and experimentation credit carryforwards........ 901,000 1,333,000 Deferred rent............................................ 550,000 626,000 Plant and equipment, principally due to differences in depreciation and capitalized interest................. -- 850,000 Deferred revenues........................................ 5,100,000 11,831,000 Foreign currency loss.................................... 66,000 375,000 Acquisition-related items................................ 2,345,000 1,994,000 U.S. net operating loss carryforwards.................... 110,000 425,000 Non-U.S. net operating loss carryforwards................ 1,119,000 954,000 Other.................................................... 285,000 1,586,000 ----------- ----------- Total gross deferred tax assets............................ 11,751,000 21,450,000 Less valuation allowance................................... (3,470,000) (2,615,000) ----------- ----------- Net deferred tax assets.................................... 8,281,000 18,835,000 ----------- ----------- Deferred tax liabilities: Capitalized software costs............................... 3,413,000 5,439,000 Acquisition-related items................................ 1,389,000 1,053,000 Post-retirement benefits................................. 544,000 1,320,000 Plant and equipment...................................... 281,000 64,000 Other.................................................... 114,000 114,000 ----------- ----------- Net deferred tax asset..................................... $ 2,540,000 $10,845,000 =========== ===========
The valuation allowance remained constant in 1998, decreased $867,000 in 1999, and decreased by $855,000 in 2000. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. As of December 31, 2000, SPSS A/S, a Danish subsidiary, had a net operating loss carryforward of approximately $2,206,000, which begins to expire in 2001. As of December 31, 2000, SPSS had a Federal research and experimentation credit carryforward of approximately $1,330,000, which begins to expire in 2001. 17 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (10) EMPLOYEE BENEFIT PLANS Effective February 1, 1995, SPSS amended its 401(k) savings plan. Qualified employees may participate in the savings plan by contributing up to the lesser of 15% of eligible compensation or limits imposed by the U.S. Internal Revenue Code in a calendar year. Beginning in 1999, SPSS made a matching contribution of $500 for employees in the plan the entire year, which resulted in a $288,000 contribution by SPSS recorded as compensation expense. Also in 1999, the plan year was changed to begin on December 31 of each year and end on December 30. In 1993, SPSS implemented an employee stock purchase plan. The SPSS purchase plan provides that eligible employees may contribute up to 10% of their base salary per quarter towards the quarterly purchase of SPSS common stock. The employee's purchase price is 85% of the fair market value of the stock at the close of the first business day after the quarterly offering period. The total number of shares issuable under the purchase plan is 100,000. Effective October 2000, the plan was amended to calculate the share price as 85% of the lower of i) the closing market price of the stock on the first trading day of the quarter, or ii) the closing market price for the stock on the last trading day after the end of the quarter. During 1998, 18,663 shares were issued under the purchase plan at market prices ranging from $19.25 to $23.75. During 1999, 18,249 shares were issued under the purchase plan at market prices ranging from $16.75 to $25.50. During 2000, 16,545 shares were issued under the purchase plan at market prices ranging from $22.06 to $31.00. SPSS recorded $54,000, $52,000 and $73,000 in compensation expense related to the purchase of these shares in 1998, 1999 and 2000, respectively. Under the ShowCase 1999 Employee Stock Purchase Plan, which became effective upon consummation of the ShowCase initial public offering, substantially all employees may purchase shares of common stock at the end of semiannual purchase periods at a price equal to the lower of 85% of the stock's fair market value on the first day or the last day of that period. Plan funding occurs throughout the purchase period by pre-elected payroll deductions of up to 15% of pay. No compensation expense results from the plan. During 1999, 11,882 shares were issued under the purchase plan at market prices averaging 4.91 per share. During 2000, 13,493 shares were issued under the purchase plan at market prices averaging 4.94 per share. During April 2001, the ShowCase profit sharing plan was merged into the SPSS 401(k) savings plan. This plan allowed ShowCase employees to defer a portion of their income through contributions to the plan. At the Company's board of director's discretion, the Company matched a percentage of employees' voluntary contributions, or made additional contributions. Employer contributions to the plan were $50,000, $193,000 and $216,000 for the years ended December 31, 1998, 1999 and 2000, respectively. (11) RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIPS SPSS entered into agreements with limited partnerships in 1981, 1982 and 1985 for the partnerships to perform research and development for new and existing computer software. Certain of the general and limited partners of these partnerships are officers of SPSS and under these agreements, SPSS incurred royalty expense to the partnerships of $235,000, $237,000 and $252,000, for the years ended December 31, 1998, 1999 and 2000, respectively. (12) STOCK OPTIONS On January 16, 1992, SPSS adopted a Stock Option Plan for some key employees. Options vest either immediately or over a four-year period. In September 1994, SPSS granted options to purchase 150,000 shares of common stock to the principal owners of SYSTAT. In addition, in June 1995, the stockholders of SPSS adopted the 1995 Equity Incentive Plan which authorizes the Board of Directors, under certain conditions, to grant stock options and shares of restricted stock to directors, officers, other key executives, employees and independent contractors. 18 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) At the 1996 meeting of SPSS shareholders, the shareholders ratified the Second Amended and Restated 1995 Equity Incentive Plan, which was amended, among other things, to increase the shares allowed to be granted under the Plan from 600,000 to 1,050,000. In May 1999, SPSS approved the Third Amended and Restated 1995 Equity Incentive Plan, which was amended to clarify the rules governing the treatment of attestation of shares given to SPSS for the exercise price of options. In May 1999, SPSS adopted the 1999 Employee Equity Incentive Plan, which authorizes the Board, under some conditions, to grant stock options and shares of restricted stock to non-executive officer employees and independent contractors of SPSS. In connection with the grant to employees of options to purchase 81,000 shares of common stock in 1999 and 527,900 shares of common stock in 1998, the Company recorded deferred compensation of $152,000 in 1999 and $355,000 in 1998. This represents the difference between the deemed value of the common stock for accounting purposes and the option exercise price of such options on the date of grant based upon the intrinsic value method in accordance with APB Opinion No. 25, Accounting for Stock Issued to Employees. Additionally the Company recorded approximately $60,000 of deferred compensation in 1999 related to stock options issued to a consultant. The Company recognized expense of approximately $116,000, $108,000 and $33,000 for the fiscal years ended December 31, 2000, 1999, and 1998, respectively, for these stock option grants and will recognize the remainder of the deferred compensation cost over the respective vesting periods (four to five years) of the options granted. The Company recognized general and administrative expense of $304,000 for compensation expense during 2000 related to accelerated vesting of options and change of employee status in accordance with Financial Accounting Standards Board Interpretation No. 44, Accounting for Certain Transactions involving Stock Compensation -- an interpretation of APB Opinion No. 25. SPSS applies APB Opinion No. 25 and related interpretations in accounting for its plans. All options under the plans have been granted at exercise prices not less than the market value at the date of the grant. Had compensation cost for SPSS' stock option plans been determined consistent with SFAS No. 123, SPSS' net income available to stockholders would have been decreased to the pro forma amounts indicated below:
YEAR ENDED DECEMBER 31, ------------------------------------- 1998 1999 2000 ---------- ----------- ---------- Net income: As reported................................... $8,640,000 $13,237,000 $5,915,000 Pro forma..................................... 5,598,000 9,735,000 3,262,000 Net earnings per share: Basic as reported............................. 0.79 1.05 0.44 Basic pro forma............................... 0.51 0.78 0.24 Diluted as reported........................... 0.73 0.98 0.41 Diluted pro forma............................. 0.47 0.72 0.23
Under the stock option plans, the exercise price of each option equals the market value of the Company's stock on the date of grant. For purposes of calculating the compensation costs consistent with SFAS No. 123, the fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for grants in fiscal 1998, 1999 and 2000, respectively; no expected dividend yield; expected volatility of 25% in 1998, 39% in 1999 and 38% in 2000; risk free interest 19 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) rates of 5.30%-5.65%, 5.65%-6.43% and 4.90%-5.65%, respectively, and expected lives of 4-8 years. Additional information regarding options is as follows:
1998 1999 2000 -------------------- -------------------- -------------------- WEIGHTED WEIGHTED WEIGHTED AVERAGE AVERAGE AVERAGE EXERCISE EXERCISE EXERCISE OPTIONS PRICE OPTIONS PRICE OPTIONS PRICE --------- -------- --------- -------- --------- -------- Outstanding at beginning of year.... 2,154,035 $11.45 2,376,362 $14.38 2,766,969 $15.72 Granted........... 687,133 17.17 621,968 17.95 743,167 21.86 Forfeited......... (223,930) 6.65 (104,431) 9.72 (209,925) 13.09 Exercised......... (240,876) 6.08 (126,930) 5.81 (389,043) 11.05 --------- ------ --------- ------ --------- ------ Outstanding at end of year................. 2,376,362 14.38 2,766,969 15.72 2,911,168 17.93 Options exercisable at year end............. 1,282,430 13.35 1,550,741 15.97 1,530,329 16.65
The weighted average fair value of options granted during 1998, 1999 and 2000 was $17.17, $17.95 and $21.86, respectively. The following table summarizes information about stock options outstanding at December 31, 2000:
WEIGHTED AVERAGE WEIGHTED WEIGHTED REMAINING AVERAGE AVERAGE OPTIONS CONTRACTUAL EXERCISE OPTIONS EXERCISE RANGE OF EXERCISE PRICES OUTSTANDING LIFE PRICE EXERCISABLE PRICE ------------------------ ----------- ----------- -------- ----------- -------- $ 0.21 - 3.24.................... 223,702 2.71 $ 1.57 196,256 $ 1.43 4.26 - 4.50.................... 87,272 7.14 4.42 28,813 4.41 8.00 - 9.125................... 119,650 2.91 8.53 119,150 8.53 11.625-15.375................... 493,044 5.64 13.65 403,227 14.00 16.05 -17.0625.................. 92,834 8.19 16.10 18,105 16.07 17.5 -24.00.................... 1,251,867 8.56 19.96 398,598 20.38 25.125-29.00.................... 642,799 7.60 26.73 366,180 27.29 --------- ---- ------ --------- ------ 2,911,168 7.12 $17.93 1,530,329 $16.65
(13) SUBSEQUENT EVENTS On October 23, 2001, the Company announced that it had entered into an agreement with America On-Line to purchase certain operating assets and maintain a strategic relationship for a four year period. Payments for assets and ongoing sample access fees will aggregate $42 million of cash and stock, and will be paid over the four year period. The acquired assets will be accounted for as a purchase by the Company. On October 29, 2001, the Company entered into an agreement and plan of merger to acquire all of the outstanding shares of NetGenesis Corporation, a leading provider of E-Metrics solutions for global 2000 companies. The Company plans to issue approximately 2.4 million shares of common stock to NetGenesis approximating $44 million and will treat the transaction as a purchase. The January 26, 2001 amendment to the line of credit with American National Bank and Trust Company discussed in Note 7 expired and was not renewed. SPSS settled its dispute with Ms. Norusis (as discussed in Note 5) without significant liability. Under the terms of settlement, SPSS received ownership rights to materials produced by Ms. Norusis prior to the settlement for approximately $1.7 million and Ms. Norusis received exclusive rights to draft three statistical manuals for SPSS software for a 10-year term, with a 10-year renewal right. 20 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) (14) UNAUDITED QUARTERLY FINANCIAL INFORMATION The following is a summary of the unaudited interim results of operations for each of the quarters ended in 1999 and 2000.
SPSS --------------------------------------------------------------------------------------- MAR. 31, JUNE 30, SEPT. 30, DEC. 31, MAR. 31, JUNE 30, SEPT. 30, DEC. 31, 1999 1999 1999 1999 2000 2000 2000 2000 -------- -------- --------- -------- -------- -------- --------- -------- (IN THOUSANDS, EXCEPT PERCENTAGE AND SHARE DATA) Net revenues: Analytical solutions........... $ 3,680 $ 3,597 $ 4,189 $ 6,074 $ 6,824 7,549 $ 7,664 $ 8,209 Market research................ 7,030 7,199 7,667 10,778 7,435 8,429 9,927 3,897 Statistics..................... 22,287 22,850 22,763 23,816 23,294 20,927 21,730 13,895 ------- ------- ------- ------- ------- ------- ------- -------- Net revenues................. 32,997 33,646 34,619 40,668 37,553 36,905 39,321 26,001 Operating expenses: Cost of revenues............... 2,683 3,126 3,253 3,601 3,174 2,804 2,960 3,296 Sales and marketing............ 16,904 16,357 16,109 18,907 19,341 18,994 20,335 22,511 Product development............ 5,709 6,215 6,581 6,478 6,162 6,692 6,609 7,150 General and administrative..... 2,415 2,985 2,607 1,766 2,481 2,393 2,358 1,981 Merger-related(a).............. -- -- -- 1,611 -- -- -- -- Acquired in-process technology(b)................ -- -- -- 128 -- -- -- -- ------- ------- ------- ------- ------- ------- ------- -------- Operating expenses........... 27,711 28,683 28,550 32,491 31,158 30,883 32,262 34,938 ------- ------- ------- ------- ------- ------- ------- -------- Operating income................. 5,286 4,963 6,069 8,177 6,395 6,022 7,059 (8,937) Net interest income (expense).... (65) (86) (332) (46) (173) (131) (182) (156) Other income (expenses).......... (115) (204) 539 (63) (377) 959 43 548 ------- ------- ------- ------- ------- ------- ------- -------- Income before income taxes....... 5,106 4,673 6,276 8,068 5,845 6,850 6,920 (8,545) Income tax expense (benefit)..... 1,766 1,774 2,195 2,886 2,316 2,698 2,725 (4,205) ------- ------- ------- ------- ------- ------- ------- -------- Net income (loss)................ $ 3,340 $ 2,899 $ 4,081 $ 5,182 $ 3,529 $ 4,152 $ 4,195 $ (4,340) ======= ======= ======= ======= ======= ======= ======= ======== Basic net income (loss) per share.......................... $ 0.35 $ 0.30 $ 0.42 $ 0.54 $ 0.37 $ 0.43 $ 0.43 $ (0.43) ======= ======= ======= ======= ======= ======= ======= ======== Shares used in basic per share... 9,581 9,656 9,606 9,621 9,679 9,740 9,863 10,012 ======= ======= ======= ======= ======= ======= ======= ======== Diluted net income (loss) per share.......................... $ 0.33 $ 0.28 $ 0.40 $ 0.51 $ 0.33 $ 0.39 $ 0.39 $ (0.43) ======= ======= ======= ======= ======= ======= ======= ======== Shares used in diluted per share.......................... 10,091 10,145 10,283 10,227 10,582 10,548 10,638 10,012 ======= ======= ======= ======= ======= ======= ======= ========
SHOWCASE --------------------------------------------------------------------------------------- MAR. 31, JUNE 30, SEPT. 30, DEC. 31, MAR. 31, JUNE 30, SEPT. 30, DEC. 31, 1999 1999 1999 1999 2000 2000 2000 2000 -------- -------- --------- -------- -------- -------- --------- -------- Net revenues: ShowCase...................... $10,257 $10,505 $ 8,506 $ 9,647 $10,865 $ 10,665 $12,229 $12,573 ------- ------- -------- -------- ------- -------- ------- ------- Net revenues................ 10,257 10,505 8,506 9,647 10,865 10,665 12,229 12,573 Operating expenses: Cost of revenues.............. 915 1,068 766 985 1,017 830 988 1,200 Sales and marketing........... 7,140 7,131 7,099 7,745 8,574 8,669 8,473 8,178 Product development........... 1,135 1,163 1,247 1,457 1,616 1,584 1,565 1,517 General and administrative.... 873 941 1,136 1,160 1,228 1,249 1,217 1,139 ------- ------- -------- -------- ------- -------- ------- ------- Operating expenses.......... 10,063 10,303 10,248 11,347 12,435 12,332 12,243 12,034 ------- ------- -------- -------- ------- -------- ------- ------- Operating income................ 194 202 (1,742) (1,700) (1,570) (1,667) (14) 539 Other income (expenses)......... 89 98 362 395 560 429 424 376 ------- ------- -------- -------- ------- -------- ------- ------- Income before income taxes...... 283 300 (1,380) (1,305) (1,010) (1,238) 410 915
21 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
SHOWCASE --------------------------------------------------------------------------------------- MAR. 31, JUNE 30, SEPT. 30, DEC. 31, MAR. 31, JUNE 30, SEPT. 30, DEC. 31, 1999 1999 1999 1999 2000 2000 2000 2000 -------- -------- --------- -------- -------- -------- --------- -------- Income tax expense (benefit).... 65 (342) (272) (257) (257) 252 352 352 ------- ------- -------- -------- ------- -------- ------- ------- Net income (loss)............... $ 218 $ 642 $ (1,108) $ (1,048) $ (753) $ (1,490) $ 58 $ 563 ======= ======= ======== ======== ======= ======== ======= ======= Basic net income (loss) per share......................... $ 0.05 $ 0.14 $ (0.11) $ (0.10) $ (0.07) $ (0.14) $ 0.01 $ 0.05 ======= ======= ======== ======== ======= ======== ======= ======= Shares used in basic per share......................... 4,495 4,542 10,139 10,368 10,485 10,572 10,760 10,784 ======= ======= ======== ======== ======= ======== ======= ======= Diluted net income (loss) per share......................... $ 0.03 $ 0.08 $ (0.11) $ (0.10) $ (0.07) $ (0.14) $ 0.01 $ 0.05 ======= ======= ======== ======== ======= ======== ======= ======= Shares used in diluted per share......................... 8,063 8,371 10,139 10,368 10,485 10,572 11,352 11,267 ======= ======= ======== ======== ======= ======== ======= =======
MAR. 31, JUNE 30, SEPT. 30, DEC. 31, MAR. 31, JUNE 30, SEPT. 30, DEC. 31, 1999* 1999* 1999* 1999* 2000 2000 2000 2000 -------- -------- --------- -------- -------- -------- --------- -------- Net revenues: Analytical solutions........... $ 3,680 $ 3,597 $ 4,189 $ 6,074 $ 6,824 7,549 $ 7,664 $ 8,209 Market research................ 7,030 7,199 7,667 10,778 7,435 8,429 9,927 3,897 Statistics..................... 22,287 22,850 22,763 23,816 23,294 20,927 21,730 13,895 ShowCase....................... 10,505 8,506 9,647 10,865 10,865 10,665 12,229 12,573 ------- ------- ------- ------- ------- ------- ------- ------- Net revenues................. 43,502 42,152 44,266 51,533 48,418 47,570 51,550 38,574 Operating expenses: Cost of revenues............... 3,751 3,892 4,238 4,618 4,191 3,634 3,948 4,496 Sales and marketing............ 24,035 23,456 23,854 27,481 27,915 27,663 28,807 30,688 Product development............ 6,872 7,462 8,038 8,094 7,778 8,276 8,174 8,667 General and administrative..... 3,356 4,121 3,767 2,993 3,709 3,642 3,575 3,120 Merger-related(a).............. -- -- -- 1,611 -- -- -- -- Acquired in-process technology(b)................ -- -- -- 128 -- -- -- -- ------- ------- ------- ------- ------- ------- ------- ------- Operating expenses........... 38,014 38,931 39,897 44,925 43,593 43,215 44,504 46,971 ------- ------- ------- ------- ------- ------- ------- ------- Operating income................. 5,488 3,221 4,369 6,608 4,825 4,355 7,046 (8,397) Other income (expenses).......... (82) 72 602 451 10 1,257 285 768 ------- ------- ------- ------- ------- ------- ------- ------- Income before income taxes....... 5,406 3,293 4,971 7,059 4,835 5,612 7,331 (7,629) Income tax expense (benefit)..... 1,424 1,502 1,938 2,628 2,059 2,950 3,077 (3,853) ------- ------- ------- ------- ------- ------- ------- ------- Net income (loss)................ $ 3,982 $ 1,791 $ 3,033 $ 4,431 $ 2,776 $ 2,662 $ 4,254 $(3,776) ======= ======= ======= ======= ======= ======= ======= ======= Basic net income (loss) per share.......................... $ 0.36 $ 0.14 $ 0.23 $ 0.34 $ 0.21 $ 0.20 $ 0.32 $ (0.28) ======= ======= ======= ======= ======= ======= ======= ======= Shares used in basic per share... 11,095 13,036 13,062 13,116 13,174 13,264 13,450 13,607 ======= ======= ======= ======= ======= ======= ======= ======= Diluted net income (loss) per share.......................... $ 0.31 $ 0.13 $ 0.22 $ 0.32 $ 0.20 $ 0.19 $ 0.30 $ (0.27) ======= ======= ======= ======= ======= ======= ======= ======= Shares used in diluted per share.......................... 12,881 13,525 13,739 13,722 14,077 14,072 14,422 13,768 ======= ======= ======= ======= ======= ======= ======= =======
--------------- * Includes ShowCase quarterly financial information for three month period following reporting date due to varying year ends. As a result, information from the quarter ended March 31, 2000 is included in the December 31, 1999 and March 31, 2000 figures. 22 SPSS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
MAR. 31, JUNE 30, SEPT. 30, DEC. 31, MAR. 31, JUNE 30, SEPT. 30, DEC. 31, 1999 1999 1999 1999 2000 2000 2000 2000 -------- -------- --------- -------- -------- -------- --------- -------- Net revenues: Analytical solutions.................. 9% 9% 10% 12% 14% 16% 15% 21% Market research....................... 16% 17% 17% 21% 15% 18% 19% 10% Statistics............................ 51% 54% 51% 46% 48% 44% 42% 36% ShowCase.............................. 24% 20% 22% 21% 23% 22% 24% 33% --- --- --- --- --- --- --- --- Net revenues........................ 100% 100% 100% 100% 100% 100% 100% 100% Operating expenses: Cost of revenues...................... 9% 9% 10% 9% 9% 8% 8% 12% Sales and marketing................... 55% 56% 54% 53% 58% 58% 56% 80% Product development................... 16% 18% 18% 16% 16% 17% 16% 22% General and administrative............ 8% 10% 9% 6% 8% 8% 7% 8% Merger-related(a)..................... -- -- -- 3% -- -- -- -- Acquired in-process technology(b)..... -- -- -- -- -- -- -- -- --- --- --- --- --- --- --- --- Operating expenses.................. 88% 93% 91% 87% 91% 91% 87% 122% --- --- --- --- --- --- --- --- Operating income........................ 12% 7% 9% 13% 9% 9% 13% (22)% Other income (expense).................. -- -- 1% 1% -- 3% 1% 2% --- --- --- --- --- --- --- --- Income before income taxes.............. 12% 7% 10% 14% 9% 12% 14% (20)% Income tax expense (benefit)............ 3% 4% 4% 5% 4% 6% 6% (10)% --- --- --- --- --- --- --- --- Net income (loss)....................... 9% 3% 6% 9% 5% 6% 8% (10)% === === === === === === === ===
--------------- (a) Includes costs related to acquisitions accounted for as poolings-of-interests, such as investment banking and other professional fees, employee severance and costs of closing excess office facilities and certain expenses associated with the closing of other acquisitions. (b) Includes costs related to acquired in-process technology in conjunction with business combinations accounted for as purchases. 23 SCHEDULE II SPSS INC. VALUATION AND QUALIFYING ACCOUNTS YEARS ENDED DECEMBER 31, 1998, 1999 AND 2000
ADDITIONS ----------------------- BALANCE AT CHARGED TO CHARGED TO BALANCE AT BEGINNING OF COSTS AND OTHER END OF DESCRIPTION PERIOD EXPENSES ACCOUNTS DEDUCTIONS PERIOD ----------- ------------ ---------- ---------- ---------- ---------- 1998 Allowance for doubtful accounts, product returns, and cancellations................... $2,214,000 $ 887,000 $2,186,000 $2,376,000 $2,911,000 Inventory obsolescence reserve.... 67,000 50,000 -- 102,000 15,000 1999 Allowance for doubtful accounts, product returns, and cancellations................... $2,911,000 $1,813,000 $1,596,000 $3,080,000 $3,240,000 Inventory obsolescence reserve.... 15,000 25,000 -- 23,000 17,000 2000 Allowance for doubtful accounts, product returns, and cancellations................... $3,240,000 $ 837,000 $3,067,000 $3,602,000 $3,542,000 Inventory obsolescence reserve.... 17,000 108,000 -- 99,000 26,000
See accompanying independent auditors' report. 24